Search for: "In re: Accutane Litigation" Results 21 - 40 of 61
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Sep 2007, 5:51 am
As readers of this blog know, we're keenly interested in Warner-Lambert v. [read post]
11 Jun 2020, 11:30 pm by Schachtman
The litigation is In re Taxotere (Docetaxel) Products Liability Litigation, a multi-district litigation (MDL) proceeding before Judge Jane Triche Milazzo, who sits on the United States District Court for the Eastern District of Louisiana. [read post]
20 Aug 2008, 5:00 am
(See In re Korean Airlines, 829 F.2d 1171 (D.C. [read post]
9 Mar 2015, 7:48 am by Schachtman
In re Accutane Litig., No. 271(MCL), 2015 WL 753674 (N.J. [read post]
27 May 2010, 3:40 pm by Bexis
”In re Norplant Contraceptive Products Liability Litigation, 1997 WL 80527 (E.D. [read post]
27 Dec 2012, 3:47 pm by Bexis
Dec. 18, 2012); Jacobsen, 2012 WL 3575293, at *9; In re Accutane Products Liability Litigation, 2012 WL 3194952, at *2-3 (M.D. [read post]
2 May 2012, 9:19 am by Emma Durand-Wood
Time just flies when you’re working hard, like our clients have been over the last month. [read post]
14 Feb 2012, 11:50 am by Michelle Yeary
  Some are shadows of their former selves; just a few cases hanging on for resolution:MDL - 986 IN RE: "Factor VIII or IX Concentrate Blood Products" Products Liability Litigation (no website)MDL-1203 IN RE Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Products Liability LitigationMDL-1431 IN RE Baycol Products Liability Litigation MDL-1596 IN RE Zyprexa Products Liability Litigation (no website)MDL-1626 IN… [read post]
14 May 2021, 9:48 am by Paul M. Hauge
Admitting their testimony on non-asbestiform, said the Appellate Division, was reversible error under the standard articulated in the New Jersey Supreme Court’s opinion in In re Accutane Litigation, which “distilled” the factors set forth in the U.S. [read post]
14 May 2021, 9:48 am by Paul M. Hauge
Admitting their testimony on non-asbestiform, said the Appellate Division, was reversible error under the standard articulated in the New Jersey Supreme Court’s opinion in In re Accutane Litigation, which “distilled” the factors set forth in the U.S. [read post]
14 May 2021, 9:48 am by Paul M. Hauge
Admitting their testimony on non-asbestiform, said the Appellate Division, was reversible error under the standard articulated in the New Jersey Supreme Court’s opinion in In re Accutane Litigation, which “distilled” the factors set forth in the U.S. [read post]
27 Oct 2011, 4:24 am by Max Kennerly, Esq.
Dec. 9, 2009)(“a jury must determine whether a reasonable person would attach significance to the off-label use of [the medical device] before deciding whether to undergo the surgery in this case”); In re Diet Drug Litigation, 384 N.J. [read post]
19 Mar 2022, 2:09 pm by admin
The important divide between regulatory practice and the litigation of causal claims in civil actions arises from the theoretical nature of the risk assessment enterprise. [read post]
8 Jul 2010, 12:56 pm by Bexis
  But at least, in Smith, the court had the fig leaf of there being only six weeks until “trial” – although we strongly doubt that all 300 cases in that litigation were actually listed for trial.Then, along came In re Diet Drug Litigation, 895 A.2d 493 (N.J. [read post]
24 Mar 2015, 12:44 pm
  See In re Accutane Products Liability, 511 F. [read post]
31 Jan 2008, 6:28 am
We're unlikely, for example, to see thousands of "Accutane caused me to commit suicide" cases. [read post]